OSAM
ICCC icon

O'Shaughnessy Asset Management’s ImmuCell ICCC Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,443
Closed -$14K – 1807
2021
Q3 		$14K Sell
1,443
-122
-8% -$1.15K ﹤0.01% 2065
2021
Q2 		$15K Sell
1,565
-1,277
-45% -$12.5K ﹤0.01% 1904
2021
Q1 		$27K Buy
+2,842
New +$26.7K ﹤0.01% 1572

Other funds holding ICCC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFW
Meristem Family Wealth Minnetonka, Minnesota $925M AUM 14.15% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

O'Shaughnessy Asset Management's ICCC Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of ImmuCell (ICCC) in Q4 2021, closing a stake of 1,443 shares — an estimated $14K sold.

O'Shaughnessy Asset Management first reported a position in ICCC in Q1 2021 and held it in 3 quarters. The position peaked at $27K in Q1 2021. 29 funds tracked by Wall St. Rank hold ICCC as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining ImmuCell position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,443 ImmuCell shares in Q4 2021, an estimated $14K.
  • O'Shaughnessy Asset Management first reported a position in ImmuCell in Q1 2021 and held it in 3 quarters.
  • O'Shaughnessy Asset Management's ImmuCell position peaked at $27K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held ImmuCell as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.